![Josh Waldman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Josh Waldman currently works at Medafor, Inc., as Chief Operating Officer & Director.
Postes actifs de Josh Waldman
Sociétés | Poste | Début |
---|---|---|
Medafor, Inc.
![]() Medafor, Inc. Medical SpecialtiesHealth Technology Medafor, Inc. develops and manufactures medical hemostatic technology. It offers AristaAH, an absorbable surgical hemostat product that is used in the control of profuse bleeding in general surgery; FlexiTip, a spray applicator for the management of bleeding or profuse following topical ENT surgical procedures; and TraumaDEX, a topical dressing for the control of severely bleeding wounds from traumatic injuries, including cuts, lacerations, and puncture wounds. The company was founded in 1999 and is headquartered in Minneapolis, MN. | Directeur des opérations | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Medafor, Inc.
![]() Medafor, Inc. Medical SpecialtiesHealth Technology Medafor, Inc. develops and manufactures medical hemostatic technology. It offers AristaAH, an absorbable surgical hemostat product that is used in the control of profuse bleeding in general surgery; FlexiTip, a spray applicator for the management of bleeding or profuse following topical ENT surgical procedures; and TraumaDEX, a topical dressing for the control of severely bleeding wounds from traumatic injuries, including cuts, lacerations, and puncture wounds. The company was founded in 1999 and is headquartered in Minneapolis, MN. | Health Technology |